drugset / Trial / NCT03023397
Evaluation of the Effect of a Nasal Allergen Challenge With Dermatophagoides Farinae Extract on Nasal Airway Inflammation in Allergic Individuals, Comparing E-cigarette Users to Cigarette Smokers and Non-smokers.
Phase 1
Terminated
12 enrolled
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI) · collab
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this pilot study is to evaluate allergen-induced nasal airway inflammation following nasal application of Dermatophagoides farinae (Der f), or house dust mite, extract in e-cigarette users, cigarette smokers, and non-smokers.
Timeline
- Start
- 2017-03-27
- Primary completion
- 2018-04-16
- Completion
- 2018-04-23
Outcome
Outcome not reported
Stopped (Business): “Lack of funding”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dermatophagoides farinae | Unknown | 100 unknown | Intranasal |
| Subject | Dermatophagoides farinae | Unknown | 500 unknown | Intranasal |
| Subject | Dermatophagoides farinae | Unknown | 1000 unknown | Intranasal |
Indications
No indication recorded.